General Information
Drug ID
DR00027
Drug Name
Ganciclovir
Synonyms
2'-NDG; 2'-Nor-2'-deoxyguanosine; 2-(6-Amino-purin-9-ylmethoxy)-propane-1,3-diol; 2-Amino-1,9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-6-H-purin-6-one; 2-Amino-9-(2-hydroxy-1-hydroxymethyl-ethoxymethyl)-1,9-dihydro-purin-6-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-1H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-3H-purin-6(9H)-one; 2-amino-9-((1,3-dihydroxypropan-2-yloxy)methyl)-9H-purin-6-ol; 2-amino-9-(1,3-dihydroxypropan-2-yloxymethyl)-3H-purin-6-one; 2-amino-9-(2-hydroxy-1-hydroxymethylethoxymethyl)-6,9-dihydro-1H-6-purinone; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-1,9-dihydro-6H-purin-6-one; 2-amino-9-{[(1,3-dihydroxypropan-2-yl)oxy]methyl}-6,9-dihydro-3H-purin-6-one; 9-((1,3-Dihydroxy-2-propoxy)methyl)guanine; 9-((2-Hydroxy-1-(hydroxymethyl)ethoxy)methyl)guanine; 9-(1,3-DIHYDROXY-PROPOXYMETHANE)GUANINE; 9-[(1,3-Dihydroxy-2-propoxy)methyl]guanine; BIOLF-62; BW 759; BW 759U; BW-759U; BW-795; BW-B 759U; Biolf 62; Citovirax; Cymevan; Cymeven; Cymevene; Cymevene (TN); Cytovene; Cytovene (TN); Cytovene-IV; DRG-0018; G 2536; GA2; GANCICLOVIR SODIUM; GCV; GCV & 1110U81; GCV & MSL; Ganciclovir & C34-dgA immunotoxin; Ganciclovir & D5-dgA immunotoxin; Ganciclovir (JAN/USP/INN); Ganciclovir [USAN:INN:BAN:JAN]; Ganciclovirum; Ganciclovirum [Latin]; Gancyclovir; Guanine, 9-((2-hydroxy-1-(hydroxymethyl)ethoxy)methyl)-and MSL, neutralizing monoclonal antibody; HHEMG; Hydroxyacyclovir; IN1478; MB3795; RS-21592; ST-605; Virgan; Vitrasert; Vitrasert (TN); Zirgan
Drug Type
Small molecular drug
Indication Cytomegalovirus infections [ICD11: 1D82] Approved [1]
Therapeutic Class
Antiviral Agents
Structure
<iframe style="width: 300px; height: 300px;" frameborder="0" src="https://embed.molview.org/v1/?mode=balls&cid=135398740"></iframe>
3D MOL 2D MOL
Formula
C9H13N5O4
Canonical SMILES
C1=NC2=C(N1COC(CO)CO)NC(=NC2=O)N
InChI
InChI=1S/C9H13N5O4/c10-9-12-7-6(8(17)13-9)11-3-14(7)4-18-5(1-15)2-16/h3,5,15-16H,1-2,4H2,(H3,10,12,13,17)
InChIKey
IRSCQMHQWWYFCW-UHFFFAOYSA-N
CAS Number
CAS 82410-32-0
Pharmaceutical Properties Molecular Weight 255.234 Topological Polar Surface Area 135
Heavy Atom Count 18 Rotatable Bond Count 5
Hydrogen Bond Donor Count 4 Hydrogen Bond Acceptor Count 6
PubChem CID
135398740
PubChem SID
10321977 , 11111224 , 11111225 , 11466867 , 11467987 , 11486454 , 12013652 , 14749970 , 14798783 , 16217245 , 17405102 , 23929519 , 24278453 , 25622077 , 26758755 , 29222588 , 3720872 , 46507294 , 47216865 , 47515408 , 47589082 , 48185084 , 48185085 , 48334596 , 48404464 , 48404465 , 49681203 , 49698657 , 49974979 , 5006228 , 50106328 , 50106329 , 50113251 , 53777645 , 53800918 , 56312143 , 56312588 , 56424026 , 57321811 , 617697 , 7298558 , 76491727 , 7840003 , 7847399 , 7887702 , 7979369 , 81041223 , 8139883 , 85231063 , 866342
ChEBI ID
ChEBI:465284
TTD Drug ID
D05ARP
DT(s) Transporting This Drug ASCT2 Transporter Info Alanine/serine/cysteine/threonine transporter 2 Substrate [2]
BCRP Transporter Info Breast cancer resistance protein Substrate [3]
MATE1 Transporter Info Multidrug and toxin extrusion protein 1 Substrate [4]
MATE2 Transporter Info Multidrug and toxin extrusion protein 2 Substrate [4]
MRP4 Transporter Info Multidrug resistance-associated protein 4 Substrate [5]
MRP5 Transporter Info Multidrug resistance-associated protein 5 Substrate [6]
OAT1 Transporter Info Organic anion transporter 1 Substrate [7]
OAT3 Transporter Info Organic anion transporter 3 Substrate [8]
OCT1 Transporter Info Organic cation transporter 1 Substrate [7]
Drug-Transporter Activity Data
Drug-Transporter Activity Data MATE1 Transporter Info Km = 5120 microM Human embryonic kidney cells (HEK293)-MATE1 [4]
MATE2 Transporter Info Km = 4280 microM Human embryonic kidney cells (HEK293)-MATE2K [4]
OAT1 Transporter Info Km = 896 microM Proximal tubule (S2) cells-OAT1 [7]
OCT1 Transporter Info Km = 516.2 microM Proximal tubule (S2) cells-OCT1 [7]
References
1 Valganciclovir was approved by FDA. The official website of the U.S. Food and Drug Administration. (2019)
2 Amino Acid Transporter ATB0,+ as a delivery system for drugs and prodrugs. Curr Drug Targets Immune Endocr Metabol Disord. 2005 Dec;5(4):357-64.
3 Side populations of glioblastoma cells are less sensitive to HSV-TK/GCV suicide gene therapy system than the non-side population. In Vitro Cell Dev Biol Anim. 2010 Jun;46(6):497-501.
4 Substrate specificity of MATE1 and MATE2-K, human multidrug and toxin extrusions/H(+)-organic cation antiporters. Biochem Pharmacol. 2007 Jul 15;74(2):359-71.
5 Human intestinal transporter database: QSAR modeling and virtual profiling of drug uptake, efflux and interactions. Pharm Res. 2013 Apr;30(4):996-1007.
6 Cellular export of drugs and signaling molecules by the ATP-binding cassette transporters MRP4 (ABCC4) and MRP5 (ABCC5). Drug Metab Rev. 2005;37(1):253-78.
7 Human organic anion transporters and human organic cation transporters mediate renal antiviral transport. J Pharmacol Exp Ther. 2002 Mar;300(3):918-24.
8 FDA Drug Development and Drug Interactions

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.